Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

BMC data: Paediatric Oncology

2nd Annual BMC Chhattisgarh Cancer Conclave / 5th Choosing Wisely 2024

20 - 23 Sep 2024

Published: 24 Sep 2024

Views: 59

Rating:

Save

Dr Ruchi Aujla -Balco Medical Center, Raipur, India

A new paediatric oncology department emphasises patient care and nutritional support. The rise in patient numbers underscores the importance of awareness and specialised treatment. Key challenges involve coordinating with subspecialities to provide comprehensive care. However, there is a positive outlook for future growth, fuelled by a strong commitment to improving services.

Related Videos

Transforming childhood cancer treatment: key insights

Dr Girish Chinnaswamy - Tata Memorial Hospital,

Transforming childhood cancer treatment: key insights ( Dr Girish Chinnaswamy - Tata Memorial Hospital, )

Cancer journeys: Research from India

Ms. Soumita Ghose - Tata Medical Center, Kolkata

Cancer journeys: Research from India ( Ms. Soumita Ghose - Tata Medical Center, Kolkata )

Special Issue on paediatric oncology

Prof Tezer Kutluk - Hacettepe University Faculty of Medicine & Cancer Institute, Sıhhiye-Ankara, Turkey

Special Issue on paediatric oncology ( Prof Tezer Kutluk - Hacettepe University Faculty of Medicine & Cancer Institute, Sıhhiye-Ankara, Turkey )

Chairperson: Evidence Communication

Dr Hemant Malhotra - Sriram Cancer Center of the Mahatma Gandhi College Hospital, Jaipur, India

Chairperson: Evidence Communication ( Dr Hemant Malhotra - Sriram Cancer Center of the Mahatma Gandhi College Hospital, Jaipur, India )

KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer

Dr Fatima Cardoso - Champalimaud Cancer Center, Lisbon, Portugal

KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer ( Dr Fatima Cardoso - Champalimaud Cancer Center, Lisbon, Portugal )

Feasibility and safety of boost at 74 Gy based on interim FDG-PET during thoracic radio-chemotherapy for NSCLC patients

Prof Gerard Zalcman - Université de Paris, Paris, France

Feasibility and safety of boost at 74 Gy based on interim FDG-PET during thoracic radio-chemotherapy for NSCLC patients ( Prof Gerard Zalcman - Université de Paris, Paris, France )

Adjuvant radiotherapy has no benefit following radical prostatectomy

Prof Noel Clarke - The Christie NHS Foundation Trust, Manchester, UK

Adjuvant radiotherapy has no benefit following radical prostatectomy ( Prof Noel Clarke - The Christie NHS Foundation Trust, Manchester, UK )

Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC

Dr Shirish Gadgeel - Henry Ford Cancer Institute, Detroit, USA

Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC ( Dr Shirish Gadgeel - Henry Ford Cancer Institute, Detroit, USA )

Short-course radiation as effective as standard treatment for breast cancer patients choosing reconstruction after mastectomy

Dr Julia Wong - Dana-Farber Brigham Cancer Center, Boston, USA

Short-course radiation as effective as standard treatment for breast cancer patients choosing reconstruction after mastectomy ( Dr Julia Wong - Dana-Farber Brigham Cancer Center, Boston, USA )

More from ecancer